LSBCF (LakeShore Biopharma Co) Treasury Stock: $0.00 Mil (As of Mar. 2025)


What is LakeShore Biopharma Co Treasury Stock?

LakeShore Biopharma Co LSBCF Treasury Stock is $0.00 Mil as of Mar. 2025.

Treasury stock is the portion of shares that a company keeps in their own treasury. LakeShore Biopharma Co's treasury stock for the quarter that ended in Mar. 2025 was $0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

LakeShore Biopharma Co Treasury Stock Historical Data

* Premium members only.

The historical data trend for LakeShore Biopharma Co's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

LakeShore Biopharma Co Treasury Stock Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
Treasury Stock
0.00 0.00 0.00 0.00 0.00

LakeShore Biopharma Co Semi-Annual Data
Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25
Treasury Stock Get a 7-Day Free Trial Premium Member Only 0.00 0.00 0.00 0.00 0.00

LakeShore Biopharma Co Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Frequently Asked Questions Learn more about Treasury Stock →
What does a Treasury Stock of $0.00 Mil mean?
LakeShore Biopharma Co (LSBCF) has a Treasury Stock of $0.00 Mil as of Mar. 2025. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for LakeShore Biopharma Co and its competitors.
Is LakeShore Biopharma Co's Treasury Stock too high?
LakeShore Biopharma Co's current Treasury Stock is $0.00 Mil.
How does LakeShore Biopharma Co's Treasury Stock compare to ACUT and PPCB?
LakeShore Biopharma Co's Treasury Stock of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Treasury Stock for a Biotechnology company?
A good Treasury Stock depends on the Biotechnology industry context. However, Treasury Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Treasury Stock mean?
A high Treasury Stock can signal that a stock is expensive relative to its fundamentals. Treasury stock is a contra-equity item that records the amount of stock not issued to shareholders. View historical data for LakeShore Biopharma Co and its competitors. LakeShore Biopharma Co's current Treasury Stock is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LakeShore Biopharma Co stock overvalued right now?
LakeShore Biopharma Co (LSBCF) has a current Treasury Stock of $0.00 Mil. The current Treasury Stock is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Treasury Stock calculated?
Treasury Stock is calculated from a company's financial statements. For LakeShore Biopharma Co (LSBCF), the current Treasury Stock is $0.00 Mil as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

LakeShore Biopharma Co Business Description

Address 38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.